pyruvaldehyde has been researched along with gw9662 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, YY; Hsu, WH; Hsu, YW; Kuo, HF; Lee, BH; Pan, TM | 1 |
1 other study(ies) available for pyruvaldehyde and gw9662
Article | Year |
---|---|
Ankaflavin: a natural novel PPARĪ³ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo.
Topics: Anilides; Animals; Anti-Inflammatory Agents; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Flavins; Gene Expression; Gene Expression Regulation; Glycation End Products, Advanced; Heme Oxygenase-1; Hypoglycemic Agents; Insulin; Insulin Resistance; Leukocytes, Mononuclear; Liver; Male; NF-E2-Related Factor 2; Oxidative Stress; Pancreas; Phosphorylation; PPAR gamma; Protein Processing, Post-Translational; Pyruvaldehyde; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Up-Regulation | 2012 |